Simple blood test may predict heart pump surgery risks

NCT ID NCT07497308

Recruiting now Knowledge-focused Sponsor: Akdeniz University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for adults with advanced heart failure who are getting a mechanical heart pump (LVAD). Researchers want to see if a substance in the blood called GDF-15 can help predict early complications or death after surgery. The goal is to better identify high-risk patients before the operation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED HEART FAILURE LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION

Contacts and locations

Locations

Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
RECRUITING

Antalya, Please Select:, 07050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.